Opinion: New "Drugs, Medical Devices and Cosmetics Bill 2022" Can Be Made Robust
It is heartening that the obsolete Drugs and Cosmetics Act 1940 is being replaced by the proposed New Drugs, Medical Devices and Cosmetics Bill (if enacted), 2022, and that suggestions and comments from the public and stakeholders are solicited.
Disclaimer: The views expressed in this article are of the author and not of the Medical Dialogues. The Editorial/Content team at Medical Dialogues has not contributed to the writing/editing/packaging of this article.
Vivek Hattangadi has an experience of 47 years in the pharmaceutical industry. He has Headed two divisions of a top Indian transnational before venturing into independent learning and developmental area. Over 17 years as an independent pharmaceutical consultant in the pharmaceutical brand management and sales management. He has written several books for the pharma industry and the entire curriculum and study material for the MBA course in pharma management for Vidyasagar University (West Bengal).